Tag - FDA

From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand

Tempus Announces the Acquisition of Paige

SCIMap: View Impact of Federal Health Research Cuts

2024 in Review

The Importance of Investment in Multimodal Data in the AI Era

2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….

The Role of the Human Gut Microbiome in Alzheimer’s Disease Development

Genome Insight Launches in the U.S. with Innovative Whole Genome Sequencing Approach that Offers Unprecedented, Actionable Insights in Cancer Care

2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress

Scientific Integrity: A Coincidental Encounter

Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance

Leading Real-World Data and Analytics Organizations Form Industry Coalition to Advance Policies to Support Regulatory Use of Real-World Evidence

COVID-19 – Viral Vector Versus mRNA Vaccines

Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide

Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

QIAGEN announces Digital Partner Program with five initial partnerships

Copyright © 2026. enlighenbio LLC. All rights reserved.